{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-004089","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2026-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.563670+00:00","generated_at":"2026-05-16T06:33:23.963848+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Calidi Biotherapeutics provides corporate update; debt reduced by $3.1M, IND planned for Q4 2026","bullets":["Term debt and notes payable reduced to $0.7M at Dec 31, 2025, from $3.8M at Dec 31, 2024 (unaudited).","G&A expenses cut by $2.3M in first nine months of 2025 vs same period 2024.","Plans to file IND for CLD-401 in Q4 2026 targeting NSCLC, triple-negative breast, and head/neck cancer.","Expects proof-of-concept data for RedTail platform in non-oncology indications and BiTE delivery with T-cell amplifiers.","New CEO Eric Poma, PhD (appointed 2025) and CMO Guy Travis Clifton, MD bring biopharma experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-004089","json":"https://secwatch.observer/filing/0001493152-26-004089.json","markdown":"https://secwatch.observer/filing/0001493152-26-004089.md","text":"https://secwatch.observer/filing/0001493152-26-004089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226004089/0001493152-26-004089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226004089/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:33:23.963848+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}